Life sciences news roundup: $175M for cell therapy; vaccine data; and more by Charlotte Schubert on March 26, 2022March 28, 2022 at 12:17 pm It was another busy week in Seattle-area biotech. Affini-T Therapeutics on Monday announced $175 million in initial financing. The company aims to move cell therapies developed at Fred Hutchinson Cancer… Read More